Consensus Sankyo Co., Ltd.

Equities

6417

JP3326410002

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
1,623 ^JPY	+0.09%		-1.64%	-1.31%

Apr. 29	AstraZeneca makes progress with Truqap and Enhertu cancer treatments	AN
Apr. 25	AstraZeneca upbeat as cancer drugs underpin sales growth	AN

Evolution of the average Target Price on Sankyo Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

e712fd6907810e9a2d60a3f502a7066e.P77nJ9m4pwL_GkJ_GuS-wjDwamp5h8Xo9goHvHIWBeU.EoyVSqr20mbSajcQSJLyigCvXVM88fHfrm1e1xNAQJF0_I8Wi9vSNI0veg~2d65523b65a5e95b50552f7882320e46

Analyst Recommendations on Sankyo Co., Ltd.

Japan's Nikkei slips after Fed chair signals delay in rate cut	Jan. 31	RE
Japanese stocks slip as economy shrinks at record rate on pandemic hit	20-08-17	RE